News
Swiss pharmaceuticals company Roche announces $50 billion investment in US over next 5 years
The Basel-based company said the investment would go toward high-tech research and development sites and new manufacturing facilities in places including Massachusetts, California, Indiana, and Pennsylvania.
Swiss drugmaker Roche is petitioning the U.S. government in direct talks for import tariff exemptions, arguing the products ...
Two of Europe’s biggest drugmakers said they’re looking at ways to protect themselves from US President Donald Trump’s ...
Roche is working to mitigate potential impacts from tariffs by moving production of its medicines to the U.S. and petitioning ...
By Dave Graham ZURICH (Reuters) -Top Swiss officials will this week test whether big commitments to the U.S. can help secure ...
Roche will invest $50 billion in U.S. manufacturing, including a new plant in Indiana. The Trump administration is ...
Roche has said it is petitioning the Trump administration for an exemption from threatened tariffs for pharmaceuticals, ...
Roche said on Tuesday it would invest $50 billion in the United States over the next five years, creating more than 12,000 ...
In today's Pharmalittle roundup, we're reading about Roche and Merck struggles with tariffs, NEJM quizzed by U.S. attorney, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback